Body Glide Muscle Formula
Natural health product licensed in Canada
- Licence holder
- Body Glide
- NPN or DIN-HM
- 80002711
- Status
- Active licence
- Licence date
- 26 January 2007
- Revision date
- Not provided
- Form
- Bâtonnet
- Route of administration
- Topique
- Application type
- TPD Cat IV/LS
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Phénoxyéthanol, Triglyceride Caprylique/caprique, propylèneglycol, Stéarate de Sodium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | Not specified | maximum: 4 Tous les jours |
Uses authorised in Canada
Temporary relief of aches and pains of muscle and joints associated with strains, sprains, and arthritic pain.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Additional directions: if condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days, discontinue use of this product and consult a physician. For children under 12 years of age, consult your health care practitioner. For external use only. If rash or irritaion occurs discontinue use. The application of external heat, such as an electric heating pad, may result in excessive skin irritation or skin burn. Do not bandage. Avoid contact with eyes and mucous membrane. Do not apply to wounds or damages skin. Do not use this product if you are allergic to salicylates or if you are taking anticoagulant medications.
- Contre-indications
Consult you health care practitioner if you are pregnant or breastfeeding prior to use.
Source
Official Health Canada record, licence 80002711
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.